Showing results (21-30 of 63) with videos related to
Sort By:
Pageof 7
La Radiologia Medica|October 18, 2022
Diagnostic and prognostic value of magnetic resonance imaging in the detection of tumor depth of invasion and bone invasion in patients with oral cavity cancerAntonio Lo Casto, Roberto Cannella, Rossana Taravella, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 26, 2024
Effect of Activated Charcoal on Mavacamten Pharmacokinetics in Healthy ParticipantsSamira Merali, Manting Chiang, Caroline Sychterz, et al.Pediatric Nephrology (Berlin, Germany)|October 22, 2005
Identification of the first AHI1 gene mutations in nephronophthisis-associated Joubert syndromeBoris Utsch, John A Sayer, Massimo Attanasio, et al.Biomed Research International|April 15, 2014
A new sampling method for spleen stiffness measurement based on quantitative acoustic radiation force impulse elastography for noninvasive assessment of esophageal varices in newly diagnosed HCV-related cirrhosisLeonardo Rizzo, Massimo Attanasio, Marilia Rita Pinzone, et al.Journal of the American Society of Nephrology : JASN|September 15, 2007
Evidence of oligogenic inheritance in nephronophthisisJulia Hoefele, Matthias T F Wolf, John F O'Toole, et al.Cancers|August 6, 2020
Optimizing Sequential Systemic Therapies for Advanced Hepatocellular Carcinoma: A Decision AnalysisGiuseppe Cabibbo, Ciro Celsa, Marco Enea, et al.Cancers|January 5, 2021
Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular CarcinomaGiuseppe Cabibbo, Ciro Celsa, Marco Enea, et al.Human Mutation|March 19, 2005
Mutational analysis of the NPHP4 gene in 250 patients with nephronophthisisJulia Hoefele, Ralf Sudbrak, Richard Reinhardt, et al.Kidney International|May 17, 2016
Loss of Glis2/NPHP7 causes kidney epithelial cell senescence and suppresses cyst growth in the Kif3a mouse model of cystic kidney diseaseDongmei Lu, Alysha Rauhauser, Binghua Li, et al.Cancer Chemotherapy and Pharmacology|July 2, 2025
Pharmacokinetics, safety, and tolerability of fedratinib in adults with moderate and severe hepatic impairment: results from the phase 1 FEDR-CP-001 trialYizhe Chen, Richard A Preston, Thomas Marbury, et al.Pageof 7